ALGIFOR Dolo Rhinogrippal caps 20 pce

7680682640010 CH-68264 M01AE51 07.10.2.
ALGIFOR Dolo Rhinogrippal caps 20 pce
google

Details

Product number
6826401
CPT
-
Packaging group
20
Unit
Kapsel(n)
Composition
ibuprofenum 200 mg, pseudoephedrini hydrochloridum 30 mg, maydis amylum, silica colloidalis anhydrica, amylum pregelificatum, carmellosum natricum conexum, acidum stearicum, natrii laurilsulfas, matériel de la capsule: gelatina, E 171, E 131, E 127, pro capsula corresp. natrium 1.19 mg.

Articles (1)

Algifor Dolo Rhinogrippal 200 mg / 30 mg, gélules
Kapseln
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/03/2025
Patient information leaflet
Français
19/03/2025
Patient information leaflet
Italien
19/03/2025
Professional SmPC
Allemand
12/03/2025
Professional SmPC
Français
12/03/2025
Professional SmPC
Italien
12/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK
(N/A)
1.19 MG Substance HBESI

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
68264
Drug name
Algifor Dolo Rhinogrippal, gélules
Galenic form
KAHA
ATC Code
M01AE51
Authorization status
Z
Dispensation category
D
First authorization
21/01/2022
Authorization expiration date
20/01/2027
IT number
07.10.2.
Domain
Human medicine

Packaging details

Description (FR)
ALGIFOR Dolo Rhinogrippal caps 20 pce
Description (DE)
ALGIFOR Dolo Rhinogrippal Kaps 20 Stk
Market launch
21/01/2022
Narcotic (BTM)
No

Other packaging sizes